Clinical Trial Update: Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental [Phase 3]

View source ↗

Summary

Phase 3 trial update showing completion status for mycophenolate mofetil in membranous nephropathy and focal segmental glomerulosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis
• Membranous Nephropathy

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Glomerulonephritis, Membranous, Glomerulosclerosis, Focal | Phase 3 | Status: COMPLETED